Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Domestic brokerage Nuvama Institutional Equities warned that Nifty 50's decline is due to weak earnings and high valuations, ...

The markets are in the red but there is no dearth of value buys. Here are some stocks that have significant upside potential ...

Given the persistent selling by global funds, Nifty recorded five consecutive months of selling - the first time in three ...

While the central bank's easing measures may provide short-term relief, global uncertainties—such as a US growth slowdown and ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Nuvama initiated coverage on Afcons Infrastructure with a ‘buy rating and Rs 535 target, citing strong financials, consistent ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

BSE stock was trading 3.76 per cent lower to ₹4,025 apiece on March 10. The stock has plunged over 10 per cent in the last ...

BSE Ltd. shares fell for the fifth consecutive session on March 11, 2025, dropping 16% this month. Nuvama cut its price ...

BSE’s index option premium market share had earlier shot up to 22.1 per cent in February 2025 from 16.4 per cent in December ...